期刊文献+

长春西汀透皮贴剂的研制及体外释药机理的探讨 被引量:4

Preparation of vinpocetine transdermal therapeutic system and study on in vitro permeation mechanism
下载PDF
导出
摘要 目的 :制备长春西汀透皮贴剂 ,研究其体外释药机理。方法 :在单层贴剂优化处方的基础上制备了单层、双层和三层贴剂 ,比较不同类型贴剂经不同皮肤的体外渗透速率 ,对三层贴剂进行了质量考察并研究了其释药机理。结果 :三层贴剂和双层贴剂的经皮渗透量大于单层贴剂。去除角质层的皮肤对药物经皮渗透的屏障作用明显小于完整皮肤。结论 :长春西汀贴剂质量可控 ,刺激性小 ,药物经皮吸收的主要屏障为角质层 ,在经皮渗透中有较微弱的储库效应 ,其渗透行为主要是零级释药模式。 OBJECTIVE To prepare the matrix-type vinpocetine transdermal therapeutic system and study the permeation mechanism. METHODS Basing on the optimized formulation of single-layered patch, single-layered,double-layered and triple-layered patch were developed. In vitro permeation studies using franz diffusion cell were carried out to compare the transdermal delivery of vinpocetine from different types of patch. Quality of triple-layered patch was examined and the permeation mechanism of vinpocetine by changing the skin condition was also studied. RESULTS The permeated amounts of vinpocetine from triple-layered patch and double-layered patch were higher than those from single-layered patch. The barrier effect of stripped stratum corneum was highly less than that of whole skin. CONCLUSION The patch of vinpocetine is well qualified without skin irritation. The transdermal barrier of vinpocetine is mainly in the stratum corneum and the deposit functionis not obvious. In vitro skin permeation of vinpocetine conforms to the zero-order behavior.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2004年第3期131-134,共4页 Chinese Journal of Hospital Pharmacy
关键词 长春西汀 透皮贴剂 体外渗透 vinpocetine transdermal patch in vitro skin permeation
  • 相关文献

参考文献5

二级参考文献10

共引文献44

同被引文献27

  • 1杨明世,游本刚,杨明华,寸冬梅,陶安进,崔福德.脱卷积法进行自制尼群地平缓释制剂体内外相关性研究[J].药学学报,2004,39(9):738-741. 被引量:17
  • 2章莉娟,钱宇,潘吉铮.聚合物载药微球活性组分控释性能的动力学模拟[J].化工学报,2006,57(8):1962-1967. 被引量:2
  • 3张馨欣,操洪欣,甘勇,朱春柳,潘卫三.羟基喜树碱纳米脂质载体的制备及体外释放[J].中国医药工业杂志,2006,37(12):820-823. 被引量:11
  • 4林亚平,周静,朱新宇.聚乙烯醇凝胶及其中药透皮给药系统的初步研究[J].中国中药杂志,1997,22(2):93-95. 被引量:21
  • 5Güngr S,zsoy Y.Systemic delivery of antihypertensive drugs via skin[J].Ther Delivery,2012,3(9):1101-1116.
  • 6Selvam RP,Singh AK,Sivakumar T.Transdermal drug delivery systems for antihypertensive drugs-a review[J].Int J Pharm Biomed Res,2010,1(1):1-8.
  • 7Gao Y,Liang J,Liu J,et al.Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol[J].Int J Pharm,2009,377(1/2):128-134.
  • 8Limpongsa E,Umprayn K.Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system[J].AAPS PharmSciTech,2008,9(2):464-470.
  • 9Draize JH,Woodard G,Calvery HO.Methods for the study of irritation and toxicity of substances applied to the skin and mucous membrane [J].J Pharmacol Exp Ther,1944,82(3):377-390.
  • 10Das MK,Bhattacharya A,Ghosal SK.Effect of different terpene-containing essential oils on percutaneous absorption of trazodone hydrochloride through mouse epidermis[J].Drug Deliv,2006,13(6):425-431.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部